Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | TPMT | P51580 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10790928 | 0.85 | HTT (0.49) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL8675250 | 0.85 | KDM4E (0.49) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL11338567 | 0.82 | HTT (0.50) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL22991582 | 0.82 | KDM4E (0.46) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL349440 | 0.82 | KDM4E (0.46) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL3156904 | 0.80 | KDM4E (0.52) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL641567 | 0.80 | POLB (0.54) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| 3,4,5-Triacetoxybenzoic Acid SCHEMBL716891 | 0.79 | KDM4E (0.63) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL29329332 | 0.79 | KDM4E (0.58) | KDM4EHSD17B10ALDH1A1HPGDGAA | |
| SCHEMBL14700588 | 0.79 | TUBB4A (0.50) | KDM4EHSD17B10ALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | claimed |
| US-12421452-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | disclosed |
| US-20240084196-A1 | METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER PROCESSED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11884864-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-01-30 | — | — | US | disclosed |
| US-20220204853-A1 | METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER PROCESSED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2022-06-30 | — | — | US | disclosed |
| CN-113748021-A | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2021-12-03 | — | — | CN | disclosed |
| US-20210361656-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | HEPALINK (HONG KONG) LIMITED (HK) | 2021-11-25 | — | — | US | disclosed |
| US-20200352946-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | RESVERLOGIX CORP. | 2020-11-12 | — | — | US | disclosed |
| US-20180104245-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | HEPALINK (HONG KONG) LIMITED (HK) | 2018-04-19 | — | — | US | disclosed |
| US-6087502-A | COMPOUNDS FOR MARKING ANTIGENS OR ANTIBODIES RECEPTOR BINDING ASSAY | MOCHIDA PHARMACEUTICALS CO., LTD. (JP) | 2000-07-11 | — | — | US | disclosed |
| EP-0761652-A1 | Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0472116-B1 | Thienopyridine Derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1996-01-31 | — | — | EP | disclosed |
| US-5256782-A | For anticholesterol agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-26 | — | — | US | disclosed |
| US-5143919-A | Acyl-CoA:cholesterol acyltransferase inhibitors; anticholesterol agents; | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-09-01 | — | — | US | disclosed |
| EP-0472116-A1 | Thienopyridine Derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1992-02-26 | — | — | EP | disclosed |
| US-4574066-A | MELT POLYMERIZATION CATALYZED BY POTASSIUM ACETATE | CELANESE CORPORATION (US) | 1986-03-04 | — | — | US | disclosed |
| US-4398015-A | POLYLACTONES; HIGH TENACITY FILAMENTS | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1983-08-09 | — | — | US | disclosed |
| EP-0026608-A1 | Aromatic polyester and filaments | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-04-08 | — | — | EP | disclosed |
| US-4232143-A | Polyester which exhibits anisotropy in the melt containing p-oxybenzoyl units and 4,4'-dioxybenzophenone units or methyl and chloro derivatives thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180104245-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | APOB, HDLBP, FABP3 | KDM4E 4404/4885HSD17B10 254/4885ALDH1A1 548/4885 |
| US-20210361656-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | APOB, HDLBP, FABP3 | KDM4E 4404/4885HSD17B10 254/4885ALDH1A1 548/4885 |
| US-20200352946-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES | APOB, HDLBP, FABP3 | KDM4E 4404/4885HSD17B10 254/4885ALDH1A1 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.